Edition:
United States

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

937.35INR
5:18am EST
Change (% chg)

Rs7.30 (+0.78%)
Prev Close
Rs930.05
Open
Rs930.10
Day's High
Rs941.40
Day's Low
Rs926.10
Volume
1,507,345
Avg. Vol
2,131,505
52-wk High
Rs1,573.60
52-wk Low
Rs806.25

Latest Key Developments (Source: Significant Developments)

Lupin Announces Pan-India Launch Of Softovac
Monday, 15 Jan 2018 03:14am EST 

Jan 15 (Reuters) - Lupin Ltd ::SAYS CO FORAYS INTO OVER-THE-COUNTER SEGMENT WITH PAN-INDIA LAUNCH OF SOFTOVAC.  Full Article

Lupin Gets FDA Approval For Generic Tamiflu Capsules
Wednesday, 10 Jan 2018 03:23am EST 

Jan 10 (Reuters) - Lupin Ltd ::LUPIN - GETS FDA APPROVAL FOR GENERIC TAMIFLU CAPSULES.  Full Article

Lupin Launches Generic Ancobon Capsules In U.S.
Friday, 5 Jan 2018 03:42am EST 

Jan 5 (Reuters) - Lupin Ltd ::SAYS LAUNCHES GENERIC ANCOBON CAPSULES IN U.S..  Full Article

Lupin Gets FDA Approval For Generic Dovonex Scalp Solution
Thursday, 28 Dec 2017 05:05am EST 

Dec 28 (Reuters) - Lupin Ltd ::GETS FDA APPROVAL FOR GENERIC DOVONEX SCALP SOLUTION.  Full Article

Lupin Gets U.S. FDA Nod For Generic Contraceptive Treatment
Thursday, 14 Dec 2017 03:31am EST 

Dec 14 (Reuters) - Lupin Ltd ::SAYS LUPIN RECEIVES FDA APPROVAL FOR GENERIC SAFYRAL TABLETS.TYDEMY AIMED TO BE USED AS A CONTRACEPTIVE AND TO RAISE FOLATE LEVELS IN WOMEN WHO CHOOSE ORAL CONTRACEPTIVE.  Full Article

Lupin says U.S. FDA issues warning letter to co's Goa, Indore sites ‍​
Tuesday, 7 Nov 2017 02:38am EST 

Nov 7 (Reuters) - Lupin Ltd :Says U.S. FDA issues warning letter to co's Goa and Indore sites .Says likely delay of new product approvals from Goa, Pithampur facilities‍​‍​.There will be no disruption of exisiting product supplies from either of these locations ‍​.  Full Article

Lupin launches generic Acticlate tablets in U.S.‍​
Thursday, 2 Nov 2017 06:54am EDT 

Nov 2 (Reuters) - Lupin Ltd ::Says co launches generic Acticlate tablets in U.S.‍​.  Full Article

Lupin says co on track with complex generic pipeline
Monday, 30 Oct 2017 04:55am EDT 

Oct 30 (Reuters) - Lupin Ltd :Says on track with complex generic pipeline.Says as expected, co continues to see pricing pressure for its U.S. generic business .Says Lupin’s Q2 North America sales 13.61 billion rupees versus 19.98 billion rupees yoy.  Full Article

India's Lupin Sept-qtr consol profit down 31 pct
Monday, 30 Oct 2017 04:51am EDT 

Oct 30 (Reuters) - Lupin Ltd ::Sept quarter consol net profit 4.55 billion rupees versus profit of 6.62 billion rupees last year.Sept quarter consol sales 38.74 billion rupees versus 42.11 billion rupees last year.Consensus forecast for Sept quarter consol profit was 4.33 billion rupees.  Full Article

Lupin gets USFDA nod for drug used in ADHD treatment
Thursday, 26 Oct 2017 05:23am EDT 

Oct 26 (Reuters) - Lupin Ltd :Says Lupin receives FDA approval for generic Kapvay extended-release tablets‍​.Drug indicated for the treatment of attention deficit hyperactivity disorder (ADHD) .  Full Article

BRIEF-Lupin Launches Generic Vibra-Tabs Tablet In U.S.

* DRUG INDICATED IN TREATMENT OF INFECTIONS CAUSED BY VARIOUS MICROORGANISMS AND AS AN ADJUNCTIVE THERAPY IN SEVERE ACNE Source text - http://bit.ly/2mVrrgE Further company coverage: